Related Experiment Videos

Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2

G Zallen1, E E Moore, D J Ciesla

  • 1Department of Surgery, Denver Health Medical Center and University of Colorado Health Sciences Center, 80204, USA.

Shock (Augusta, Ga.)
|January 19, 2000
PubMed

Insights

Stored packed red blood cells (PRBCs) can activate neutrophils (PMNs), leading to the release of inflammatory cytokines IL-8 and sPLA2. This suggests PRBC transfusions may be a preventable inflammatory trigger.

Area of Science:

  • Immunology
  • Hematology
  • Critical Care Medicine

Background:

  • Packed red blood cell (PRBC) transfusions have been linked to immunosuppression and infections.
  • Stored PRBCs (>14 days) may prime neutrophils (PMNs) and contribute to multiple organ failure (MOF).
  • Neutrophil-derived inflammatory cytokines, including IL-1, IL-8, TNFalpha, and secretory phospholipase A2 (sPLA2), are implicated in MOF.

Purpose of the Study:

  • To investigate the hypothesis that stored PRBCs act as a secondary inflammatory event by stimulating cytokine release from PMNs.
  • To determine if plasma from stored PRBCs can induce the release of inflammatory cytokines from isolated human PMNs.

Main Methods:

  • Isolated human PMNs were incubated with either fresh plasma or plasma from 42-day-old PRBCs.
  • The release of IL-8, IL-1beta, TNFalpha, and sPLA2 from PMNs was measured.
  • Plasma from stored PRBCs was analyzed for baseline cytokine levels.

Main Results:

  • Plasma from stored PRBCs contained detectable levels of IL-8, sPLA2, and TNFalpha.
  • Stored PRBC plasma significantly stimulated PMN release of IL-8 and sPLA2 compared to control and fresh plasma.
  • Stored PRBC plasma did not stimulate the release of IL-1beta or TNFalpha from PMNs.

Conclusions:

  • Transfusion of stored PRBCs can act as an inflammatory agent, priming PMNs.
  • PRBC plasma selectively activates PMNs to release IL-8 and sPLA2.
  • Modifying blood banking and transfusion practices could mitigate the inflammatory insult associated with PRBC transfusions.

Related Concept Videos